XAIR
Closed
Beyond Air Inc
0.41
0.00 (0.00%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 0.41
Day's Range: 0.4 - 0.4342
Send
sign up or login to leave a comment!
When Written:
6.75
Beyond Air Inc is a medical device and biopharmaceutical company that develops and markets innovative products for the treatment of respiratory and other diseases. The company was founded in 2011 and is headquartered in Garden City, New York.
Beyond Air's flagship product is the LungFit™ system, a nitric oxide delivery system for the treatment of respiratory conditions such as bronchiolitis, pneumonia, and COVID-19. The system delivers a precise dose of nitric oxide directly to the lungs, helping to improve oxygenation and reduce inflammation.
Beyond Air is also developing a pipeline of other products, including a nitric oxide generator for use in the treatment of pulmonary hypertension and a nitric oxide-releasing molecule for the treatment of solid tumors.
The company is publicly traded on the NASDAQ under the ticker symbol "XAIR" and has partnerships with several major healthcare companies, including AstraZeneca and Circassia Pharmaceuticals.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Beyond Air's flagship product is the LungFit™ system, a nitric oxide delivery system for the treatment of respiratory conditions such as bronchiolitis, pneumonia, and COVID-19. The system delivers a precise dose of nitric oxide directly to the lungs, helping to improve oxygenation and reduce inflammation.
Beyond Air is also developing a pipeline of other products, including a nitric oxide generator for use in the treatment of pulmonary hypertension and a nitric oxide-releasing molecule for the treatment of solid tumors.
The company is publicly traded on the NASDAQ under the ticker symbol "XAIR" and has partnerships with several major healthcare companies, including AstraZeneca and Circassia Pharmaceuticals.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!